Literature DB >> 24078147

Effect of bioconversion conditions on vanillin production by Amycolatopsis sp. ATCC 39116 through an analysis of competing by-product formation.

Xiao-kui Ma, Andrew J Daugulis.   

Abstract

This study investigated the effects of transformation conditions such as initial pH, the initial concentration of glucose and yeast extract in the medium, and the separate addition of ferulic acid and vanillic acid, on the production of vanillin through an analysis of competing by-product formation by Amycolatopsis sp. ATCC 39116. The extent and nature of by-product formation and vanillin yield were affected by initial pH and different initial concentrations of glucose and yeast extract in the medium, with a high yield of vanillin and high cell density obtained at pH 8.0, 10 g/l glucose, and 8 g/l yeast extract. High concentrations of ferulic acid were found to negatively affect cell density. Additional supplementation of 100 mg/l vanillic acid, a metabolically linked by-product, was found to result in a high concentration of vanillin and guaiacol, an intermediate of vanillin. Via an analysis of the effect of these transformation conditions on competing by-product formation, high concentrations of ferulic acid were transformed with a molar yield to vanillin of 96.1 and 95.2 %, by Amycolatopsis sp. ATCC 39116 and Streptomyces V1, respectively, together with a minor accumulation of by-products. These are among the highest performance values reported in the literature to date for Streptomyces in batch cultures.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24078147     DOI: 10.1007/s00449-013-1060-x

Source DB:  PubMed          Journal:  Bioprocess Biosyst Eng        ISSN: 1615-7591            Impact factor:   3.210


  8 in total

1.  Optimizing bioconversion of ferulic acid to vanillin by Bacillus subtilis in the stirred packed reactor using Box-Behnken design and desirability function.

Authors:  Peng Chen; Lei Yan; Shuang Zhang; Zhengrong Wu; Suyue Li; Xiaojuan Yan; Ningbo Wang; Ning Liang; Hongyu Li
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

2.  Development of an Improved System for the Generation of Knockout Mutants of Amycolatopsis sp. Strain ATCC 39116.

Authors:  Florian Meyer; Hilke Pupkes; Alexander Steinbüchel
Journal:  Appl Environ Microbiol       Date:  2017-01-17       Impact factor: 4.792

Review 3.  Biosynthesis of vanillin by different microorganisms: a review.

Authors:  Qianqian Ma; Liwen Liu; Shuo Zhao; Zhaosong Huang; Changtao Li; Shuixing Jiang; Qiang Li; Pengfei Gu
Journal:  World J Microbiol Biotechnol       Date:  2022-01-12       Impact factor: 3.312

4.  Metabolic Engineering of the Actinomycete Amycolatopsis sp. Strain ATCC 39116 towards Enhanced Production of Natural Vanillin.

Authors:  Christian Fleige; Florian Meyer; Alexander Steinbüchel
Journal:  Appl Environ Microbiol       Date:  2016-05-16       Impact factor: 4.792

5.  Proteomic Profiling, Transcription Factor Modeling, and Genomics of Evolved Tolerant Strains Elucidate Mechanisms of Vanillin Toxicity in Escherichia coli.

Authors:  Calum A Pattrick; Joseph P Webb; Jeffrey Green; Roy R Chaudhuri; Mark O Collins; David J Kelly
Journal:  mSystems       Date:  2019-06-11       Impact factor: 6.496

Review 6.  Depolymerization and conversion of lignin to value-added bioproducts by microbial and enzymatic catalysis.

Authors:  Caihong Weng; Xiaowei Peng; Yejun Han
Journal:  Biotechnol Biofuels       Date:  2021-04-03       Impact factor: 6.040

7.  Comparative Analysis of Bio-Vanillin Recovery from Bioconversion Media Using Pervaporation and Vacuum Distillation.

Authors:  Rita Valério; Carla Brazinha; João G Crespo
Journal:  Membranes (Basel)       Date:  2022-08-19

8.  Feeding strategies to optimize vanillin production by Amycolatopsis sp. ATCC 39116.

Authors:  Rita Valério; Ana R S Bernardino; Cristiana A V Torres; Carla Brazinha; Maria L Tavares; João G Crespo; Maria A M Reis
Journal:  Bioprocess Biosyst Eng       Date:  2021-01-02       Impact factor: 3.210

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.